FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Luc Fauchère

Research Profile

Genes & Molecular Sequences

Amino Acid Sequences

Living Beings

Concepts & Ideas

Chemicals & Drugs

Occupations

Drug Design

Procedures

Mass Spectrometry

Co-author Network

Publications

TOP 3
Valérie Audinot; Odile Della Zuana; Nelly Fabry; C Ouvry; Olivier Nosjean; JM Henlin; Jean-Luc Fauchère; Jean A Boutin
S38151 [p-guanidinobenzoyl-[Des-Gly(10)]-MCH(7-17)] is a potent and selective antagonist at the MCH(1) receptor and has anti-feeding properties in vivo.
Odile Della Zuana; L Revereault; Annette G Beck-Sickinger; A Monge; Daniel-Henri Caignard; Jean-Luc Fauchère; JM Henlin; Valérie Audinot; Jean A Boutin; S Chamorro; Michel Félétou; Nigel Levens
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.
Thierry Le Diguarher; Jean-Claude Ortuno; David Shanks; Nicolas Guilbaud; Alain Pierré; Eric Raimbaud; Jean-Luc Fauchère; John A Hickman; Gordon C Tucker; Patrick J Casara
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Luc Fauchère (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Valérie Audinot; Odile Della Zuana; Nelly Fabry; C Ouvry; Olivier Nosjean; JM Henlin; Jean-Luc Fauchère; Jean A Boutin
S38151 [p-guanidinobenzoyl-[Des-Gly(10)]-MCH(7-17)] is a potent and selective antagonist at the MCH(1) receptor and has anti-feeding properties in vivo.
Peptides 2009;30(11):1997-2007.
2004: Odile Della Zuana; L Revereault; Annette G Beck-Sickinger; A Monge; Daniel-Henri Caignard; Jean-Luc Fauchère; JM Henlin; Valérie Audinot; Jean A Boutin; S Chamorro; Michel Félétou; Nigel Levens
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(4):628-39.
2004: Thierry Le Diguarher; Jean-Claude Ortuno; David Shanks; Nicolas Guilbaud; Alain Pierré; Eric Raimbaud; Jean-Luc Fauchère; John A Hickman; Gordon C Tucker; Patrick J Casara
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.
Bioorganic & medicinal chemistry letters 2004;14(3):767-71.
2003: Thierry Le Diguarher; Jean-Claude Ortuno; Gilbert Dorey; David Shanks; Nicolas Guilbaud; Alain Pierré; Jean-Luc Fauchère; John A Hickman; Gordon C Tucker; Patrick J Casara
Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.
Bioorganic & medicinal chemistry 2003;11(14):3193-204.
2002: Valérie Audinot; Chantal Lahaye; Thomas Suply; Carole Rovère-Jovène; Marianne Rodriguez; Jean-Paul Nicolas; Philippe Beauverger; Bruno Cardinaud; Jean-Pierre Galizzi; Jean-Luc Fauchère; Jean-Louis Nahon; Jean A Boutin
SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptor.
Biochemical and biophysical research communications 2002;295(4):841-8.
2002: Jean A Boutin; Thomas Suply; Valérie Audinot; Marianne Rodriguez; Philippe Beauverger; Jean-Paul Nicolas; Jean-Pierre Galizzi; Jean-Luc Fauchère
Melanin-concentrating hormone and its receptors: state of the art.
Canadian journal of physiology and pharmacology 2002;80(5):388-95.
2002: S Chamorro; Odile Della Zuana; Jean-Luc Fauchère; Michel Félétou; Jean-Pierre Galizzi; Nigel Levens
Appetite suppression based on selective inhibition of NPY receptors.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(3):281-98.
2002: Anne-Marie Chollet; Thierry Le Diguarher; Nathalie Kucharczyk; Armelle Loynel; Marc Bertrand; Gordon Tucker; Nicolas Guilbaud; Mike Burbridge; Philippe Pastoureau; Armel Fradin; Massimo Sabatini; Jean-Luc Fauchère; Patrick J Casara
Solid-phase synthesis of alpha-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors.
Bioorganic & medicinal chemistry 2002;10(3):531-44.
2001: Pierre-Hervé Lambert; Sophie Bertin; Jean-Luc Fauchère; Jean-Paul Volland
Quality assessment of combinatorial pooled libraries using mass spectrometry.
Combinatorial chemistry & high throughput screening 2001;4(4):317-32.
2001: Valérie Audinot; Chantal Lahaye; Thomas Suply; Philippe Beauverger; Marianne Rodriguez; Jean-Pierre Galizzi; Jean-Luc Fauchère; Jean A Boutin
[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor.
British journal of pharmacology 2001;133(3):371-8.
2001: JM Henlin; Jean A Boutin; F Duchêne-Roger; Jean-Paul Nicolas; C Desmet-Beaufort; Nigel Levens; Jean-Luc Fauchère
Parallel synthesis and pharmacological screening of nonpeptide ligands of the neuropeptide Y receptor subtype Y5.
The journal of peptide research : official journal of the American Peptide Society 2001;57(5):419-27.
2000: Gilles Ferry; Armelle Loynel; Nathalie Kucharczyk; Sophie Bertin; Marianne Rodriguez; Philippe Delagrange; Jean-Pierre Galizzi; E Jacoby; Jean-Paul Volland; Daniel Lesieur; Pierre Renard; Emmanuel Canet; Jean-Luc Fauchère; Jean A Boutin
Substrate specificity and inhibition studies of human serotonin N-acetyltransferase.
The Journal of biological chemistry 2000;275(12):8794-805.
2000: Jacques Duhault; Michelle Boulanger; S Chamorro; Jean A Boutin; Odile Della Zuana; E Douillet; Jean-Luc Fauchère; Michel Félétou; M Germain; B Husson; A M Vega; Pierre Renard; F Tisserand
Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
Canadian journal of physiology and pharmacology 2000;78(2):173-85.
1999: Jean A Boutin; Pierre-Hervé Lambert; Sophie Bertin; Jean-Paul Volland; Jean-Luc Fauchère
Physico-chemical and biological analysis of true combinatorial libraries.
Journal of chromatography. B, Biomedical sciences and applications 1999;725(1):17-37.
1999: Jean A Boutin; W Marande; L Petit; Armelle Loynel; C Desmet; Emmanuel Canet; Jean-Luc Fauchère
Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries.
Cellular signalling 1999;11(1):59-69.
1998: Michel Félétou; Marianne Rodriguez; Philippe Beauverger; M Germain; Jérôme Imbert; Sandra Dromaint; Christelle Macia; A Bourrienne; JM Henlin; Jean-Paul Nicolas; Jean A Boutin; Jean-Pierre Galizzi; Jean-Luc Fauchère; Emmanuel Canet; Jacques Duhault
NPY receptor subtypes involved in the contraction of the proximal colon of the rat.
Regulatory peptides 1998;75-76():221-9.
1998: Gilles Ferry; Jean A Boutin; Philippe Hennig; Annie Genton; C Desmet; Jean-Luc Fauchère; Ghanem Atassi; Gordon C Tucker
A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects.
European journal of pharmacology 1998;351(2):225-33.
1997: E Jacoby; A Boudon; Nathalie Kucharczyk; A Michel; Jean-Luc Fauchère
A structural rationale for the design of water soluble peptide-derived neurokinin-1 antagonists.
Journal of receptor and signal transduction research 1997;17(6):855-73.
1997: Jean-Luc Fauchère; JM Henlin; Jean A Boutin
Peptide and nonpeptide lead discovery using robotically synthesized soluble libraries.
Canadian journal of physiology and pharmacology 1997;75(6):683-9.
1997: Jean A Boutin; I Gesson; JM Henlin; Sophie Bertin; Pierre-Hervé Lambert; Jean-Paul Volland; Jean-Luc Fauchère
Limitations of the coupling of amino acid mixtures for the preparation of equimolar peptide libraries.
Molecular diversity 1997;3(1):43-60.
1997: Gilles Ferry; Jean A Boutin; Ghanem Atassi; Jean-Luc Fauchère; Gordon C Tucker
Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.
Molecular diversity 1997;2(3):135-46.
1996: J Bonnet; N Kucharczyk; P Robineau; Michel Lonchampt; C Dacquet; D Regoli; Jean-Luc Fauchère; Emmanuel Canet
A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523.
European journal of pharmacology 1996;310(1):37-46.
1996: R A Buono; N Kucharczyk; M Neuenschwander; J Kemmink; L Y Hwang; Jean-Luc Fauchère; C A Venanzi
Synthesis and conformational analysis by 1H NMR and restrained molecular dynamics simulations of the cyclic decapeptide [Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly].
Journal of computer-aided molecular design 1996;10(3):213-32.
1996: C Thurieau; Michel Félétou; P Hennig; E Raimbaud; Emmanuel Canet; Jean-Luc Fauchère
Design and synthesis of new linear and cyclic bradykinin antagonists.
Journal of medicinal chemistry 1996;39(10):2095-101.
1996: Michel Félétou; I Jamonneau; M Germain; C Thurieau; Jean-Luc Fauchère; P Villa; P Ghezzi; Emmanuel Canet
Bradykinin B2 receptor involvement in rabbit and murine models of septic shock.
Journal of cardiovascular pharmacology 1996;27(4):500-7.
1996: Jean A Boutin; P Hennig; P H Lambert; Sophie Bertin; L Petit; J P Mahieu; B Serkiz; Jean-Paul Volland; Jean-Luc Fauchère
Combinatorial peptide libraries: robotic synthesis and analysis by nuclear magnetic resonance, mass spectrometry, tandem mass spectrometry, and high-performance capillary electrophoresis techniques.
Analytical biochemistry 1996;234(2):126-41.
1996: P Hennig; E Raimbaud; C Thurieau; Jean-Paul Volland; A Michel; Jean-Luc Fauchère
Solution conformation by NMR and molecular modeling of three sulfide-free somatostatin octapeptide analogs compared to angiopeptin.
Journal of computer-aided molecular design 1996;10(1):83-6.
1996: M Sabatini; C Lesur; M Pacherie; P Pastoureau; N Kucharczyk; Jean-Luc Fauchère; J Bonnet
Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferation.
Bone 1996;18(1):59-65.
1995: Michel Félétou; Michel Lonchampt; P Robineau; I Jamonneau; C Thurieau; Jean-Luc Fauchère; P Villa; P Ghezzi; J F Prost; Emmanuel Canet
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1078-84.
1995: Michel Félétou; P Robineau; Michel Lonchampt; E Bonnardel; C Thurieau; Jean-Luc Fauchère; P Widdowson; J P Mahieu; B Serkiz; Jean-Paul Volland
S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1071-7.
1995: Michel Félétou; C A Martin; mathieu molimard; Emmanuel Naline; M Germain; C Thurieau; Jean-Luc Fauchère; Emmanuel Canet; Charles Advenier
In vitro effects of HOE 140 in human bronchial and vascular tissue.
European journal of pharmacology 1995;274(1-3):57-64.
1994: Michel Félétou; M Germain; C Thurieau; Jean-Luc Fauchère; Emmanuel Canet
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.
British journal of pharmacology 1994;112(2):683-9.
1994: C Thurieau; Serge Simonet; J Paladino; J F Prost; Tony J Verbeuren; Jean-Luc Fauchère
New N alpha-guanidinobenzoyl derivatives of hirudin-54-65 containing stabilized carboxyl or phosphoryl groups on the side chain of phenylalanine-63.
Journal of medicinal chemistry 1994;37(5):625-9.
1993: Jean-Luc Fauchère; A D Morris; C Thurieau; Serge Simonet; Tony J Verbeuren; NELLY KIEFFER
Modulation of the activity and assessment of the receptor selectivity in a series of new RGD-containing peptides.
International journal of peptide and protein research 1993;42(5):440-4.
1993: J Paladino; C Thurieau; A D Morris; N Kucharczyk; N Rouissi; D Regoli; Jean-Luc Fauchère
Synthesis and in vitro activities of new tryptophan-modified and thiomethylene-containing pseudopeptide antagonists of the neurokinins.
International journal of peptide and protein research 1993;42(3):284-93.
1993: N Kucharczyk; C Thurieau; J Paladino; A D Morris; J Bonnet; Emmanuel Canet; J E Krause; D Regoli; R Couture; Jean-Luc Fauchère
Tetrapeptide tachykinin antagonists: synthesis and modulation of the physicochemical and pharmacological properties of a new series of partially cyclic analogs.
Journal of medicinal chemistry 1993;36(11):1654-61.
1992: Serge Simonet; E Bonhomme; Michel Laubie; C Thurieau; Jean-Luc Fauchère; Tony J Verbeuren
Venous and arterial endothelial cells respond differently to thrombin and its endogenous receptor agonist.
European journal of pharmacology 1992;216(1):135-7.